Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Bronchoscopy & lung nodule · California | Bronchoscopy & lung nodule · Arizona | |
|---|---|---|
| Surgeons, 2024 | 119 | 38 |
| Medicare fee-for-service cases | 8,499 | 3,079 |
| Growth since 2019 (Medicare FFS) | +11%/yr | +16%/yr |
| Forecast cases (Medicare FFS) | 16,800 in 2030 | 5,590 in 2030 |
| Forecast growth | +12%/yr to 2030 | +10%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 2.6 | 4.2 |
| Medicare Advantage share | 56% | 54% |
| Out of hospital | 2% (+2 pts since 2019) | 0% (+0 pts since 2019) |
| Cases per surgeon | 71 | 81 |
| Top 10 surgeons' share | 33% | 63% |
| Surgeons growing | 24 | 7 |
| New since the base year | 33 | 12 |
| Likely to stop billing it | 23 by 2026 | 2 by 2026 |
| Forecast miss, 1 year (procedure) | 6% | 6% |
| Company payments per surgeon | $14K | $3,411 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.